Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Rating of "Moderate Buy" by Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has earned an average rating of "Moderate Buy" from the nine research firms that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $88.67.

ACHC has been the subject of several analyst reports. Mizuho cut their price target on Acadia Healthcare from $84.00 to $70.00 and set a "neutral" rating for the company in a research note on Friday, May 3rd. TD Cowen lifted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the company an "outperform" rating in a report on Friday, March 1st. Cantor Fitzgerald reissued a "neutral" rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 price objective for the company in a research report on Thursday, April 25th. Finally, Barclays decreased their target price on shares of Acadia Healthcare from $91.00 to $89.00 and set an "overweight" rating on the stock in a research report on Wednesday.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ACHC. Raymond James & Associates increased its stake in Acadia Healthcare by 0.6% in the third quarter. Raymond James & Associates now owns 76,048 shares of the company's stock valued at $5,347,000 after purchasing an additional 424 shares during the last quarter. Advisor Partners II LLC grew its holdings in Acadia Healthcare by 7.5% in the third quarter. Advisor Partners II LLC now owns 3,351 shares of the company's stock valued at $236,000 after purchasing an additional 234 shares during the period. Park Avenue Securities LLC purchased a new position in Acadia Healthcare during the third quarter worth approximately $316,000. Teacher Retirement System of Texas grew its stake in shares of Acadia Healthcare by 10.3% during the 3rd quarter. Teacher Retirement System of Texas now owns 29,551 shares of the company's stock valued at $2,078,000 after buying an additional 2,766 shares during the period. Finally, OFI Invest Asset Management raised its position in shares of Acadia Healthcare by 290.5% in the 3rd quarter. OFI Invest Asset Management now owns 331,129 shares of the company's stock worth $21,990,000 after buying an additional 246,322 shares during the period.

Acadia Healthcare Stock Performance

ACHC stock traded down $2.16 on Thursday, hitting $66.63. The company's stock had a trading volume of 962,718 shares, compared to its average volume of 666,807. The stock has a market cap of $6.18 billion, a price-to-earnings ratio of -491.32, a price-to-earnings-growth ratio of 2.13 and a beta of 1.31. The firm has a 50 day moving average of $74.30 and a two-hundred day moving average of $77.22. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. Acadia Healthcare has a 1 year low of $64.74 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The business had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business's quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.75 earnings per share. Equities analysts predict that Acadia Healthcare will post 3.55 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.